Janet Jill Hopkins - 16 Oct 2023 Form 3 Insider Report for Aura Biosciences, Inc. (AURA)

Role: Chief Medical Officer and President of Research and Development; Exhibit 24.1 - Power of Attorney
Signature: /s/ Julie Feder, Attorney-in-fact
Issuer symbol: AURA
Transactions as of: 16 Oct 2023
Net transactions value: $0
Form type: 3
Filing time: 23 Oct 2023, 20:51:31 UTC
Next filing: 03 Nov 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Chief Medical Officer and President of Research and Development; Exhibit 24.1 - Power of Attorney